Sakiko Fukuda-Parr, Professor and director of the Julien J. Studley Graduate Programs in International Affairs, recently co-signed an open letter calling for a ‘peoples’ vaccine for COVID-19 with Presidents Ramaphosa of South Africa, former Prime Minister Gorden Brown of UK, and dozens of other present and former heads of state, political leaders, and leading academics. When a safe and effective COVID-19 vaccine is developed, it will only be accessible to all people in all countries if it is produced in time and at scale, affordably priced, and available. This will not be possible if the vaccines are produced and distributed under the prevailing market model of private finance and monopoly protection. As world leaders commit to ensuring equitable access to vaccines, treatment and diagnostics, new models of production, pricing and patent protection are being devised. In a forthcoming webinar on May 28, Global Access to Vaccines: the Politics of Negotiations and the Global South, speakers from Brazil, India and The Netherlands will discuss the politics that are shaping the negotiations, and the role played by the Global South and civil society.
For more information on the peoples’ vaccine efforts, see the Financial Times recent article, ‘People’s vaccine’ for coronavirus must be free, leaders urge.